Dr. Sandeep Bansal
Claim this profileGSK Investigational Site
Studies Asthma
Studies Chronic Obstructive Pulmonary Disease
16 reported clinical trials
21 drugs studied
Affiliated Hospitals
Clinical Trials Sandeep Bansal is currently running
Salbutamol Inhalers
for Asthma
The goal of this study is to assess and compare the safety and tolerability of salbutamol administered via metered dose inhaler (MDI) containing propellant 1,1-difluoroethane (HFA-152a) or 1,1,1,2-tetrafluoroethane (HFA-134a) in participants aged \>=18 years with asthma.
Recruiting2 awards Phase 3
Depemokimab
for Asthma
This trial is testing a new medication called Depemokimab for people with severe asthma who have high levels of certain white blood cells. The goal is to see if switching to Depemokimab works as well as their current treatments. The medication aims to reduce these white blood cells to help control asthma symptoms.
Recruiting1 award Phase 36 criteria
More about Sandeep Bansal
Clinical Trial Related1 year of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Sandeep Bansal has experience with
- GSK3511294 (Depemokimab)
- Mepolizumab
- Zephyr Valve Procedure
- Robotic Assisted Bronchoscopy
- MRI
- Ensifentrine
Breakdown of trials Sandeep Bansal has run
Chronic Obstructive Pulmonary Disease
- Mepolizumab for Chronic Obstructive Pulmonary Disease
- A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
- A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
Lung Cancer
Obstructive Lung Diseases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sandeep Bansal specialize in?
Sandeep Bansal focuses on Asthma and Chronic Obstructive Pulmonary Disease. In particular, much of their work with Asthma has involved treating patients, or patients who are undergoing treatment.
Is Sandeep Bansal currently recruiting for clinical trials?
Yes, Sandeep Bansal is currently recruiting for 5 clinical trials in DuBois Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Sandeep Bansal has studied deeply?
Yes, Sandeep Bansal has studied treatments such as GSK3511294 (Depemokimab), Mepolizumab, Zephyr Valve Procedure.
What is the best way to schedule an appointment with Sandeep Bansal?
Apply for one of the trials that Sandeep Bansal is conducting.
What is the office address of Sandeep Bansal?
The office of Sandeep Bansal is located at: GSK Investigational Site, DuBois, Pennsylvania 15801 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.